Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Yang, Boyu [1 ]
Wu, Shaowen [1 ]
Yu, Shanshan [1 ]
Liang, Xiaoling [1 ]
Liu, Qifa [2 ]
Huang, Fen [2 ]
Liang, Lingyi [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangdong Prov Clin Res Ctr Ocular Dis,State Key, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
BONE-MARROW-TRANSPLANTATION; VISUAL-EVOKED POTENTIALS; VERSUS-HOST-DISEASE; CYTOMEGALOVIRUS RETINITIS; OCULAR FINDINGS; SOLID-ORGAN; EYE;
D O I
10.1038/s41433-022-02250-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To study the posterior segment complications (PSC) and the risk factors in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Methods This cross-sectional, case-control study enroled 143 patients who received allogeneic HSCT. Comprehensive ocular examinations were performed to evaluate PSC and ocular Graft-versus-Host Disease (oGVHD). PSC was diagnosed based on the characteristic fundus findings and auxiliary examinations. Visual-evoked potential was examined in patients with unexplained visual loss and suspected visual pathway pathology (VPP). Ocular surface disease index, corneal fluorescein staining, conjunctival injection and Schirmer's test were scored to diagnose oGVHD. Results PSC was detected in 36 (25.2%) patients, while 107 (74.8%) patients were not. Among them, 102 (71.3%) patients were diagnosed with oGVHD. The most common PSC included cytomegalovirus retinitis (13/143, 9.1%) and VPP (7/143, 4.9%). Central nervous system relapse of leukaemia was detected in four out of seven cases of VPP. Patients with PSC had worse visual acuity, lower prevalence and milder severity of oGVHD, and more donors from unrelated and human leucocyte antigen (HLA)-mismatch (all P < 0.05). PSC was associated with transplant from unrelated (OR = 6.494, 95% CI: 1.635-25.794, P = 0.008) and HLA-mismatched (OR = 7.193, 95% CI: 2.829-18.291, P < 0.001) donor but not with the occurrence of systemic GVHD or oGVHD. Conclusions PSC in post-HSCT patients was more common than previously noted, deserving the concern of ophthalmologists, especially in patients with unrelated or HLA-mismatched donors.
引用
收藏
页码:1816 / 1821
页数:6
相关论文
共 50 条
  • [21] Advances in the ocular complications after hematopoietic stem cell transplantation
    Lv, Xiaoli
    Li, Huibo
    Su, Sheng
    Fan, Shengjin
    ANNALS OF HEMATOLOGY, 2024, 103 (10) : 3867 - 3880
  • [22] Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation
    Bieri, Sabine
    Roosnek, Eddy
    Ozsahin, Hulya
    Huguet, Saadia
    Ansari, Marc
    Trombetti, Andrea
    Helg, Claudine
    Chapuis, Bernard
    Miralbell, Raymond
    Passweg, Jakob
    Chalandon, Yves
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (02) : 138 - 147
  • [23] Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation
    Wang, Xing-Lin
    Han, Wei
    Zhao, Peng
    Liu, Xiao
    Wang, Jing-Zhi
    Wang, Feng-Rong
    Yan, Chen-Hua
    Zhang, Yuan-Yuan
    Mo, Xiao-Dong
    Wang, Yu
    Fu, Hai-Xia
    Chen, Yu-Hong
    Chang, Ying-Jun
    Xu, Lan-Ping
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Zhang, Xiao-Hui
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (06) : 1171 - 1178
  • [24] Neuromuscular complications after hematopoietic stem cell transplantation
    Koeppen, Susanne
    Thirugnanasambanthan, Abhiyrahmi
    Koldehoff, Michael
    SUPPORTIVE CARE IN CANCER, 2014, 22 (09) : 2337 - 2341
  • [25] Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation
    Kubo, Hiroyuki
    Imataki, Osamu
    Fukumoto, Tetsuya
    Oku, Maki
    Ishida, Tomoya
    Kubo, Yukiko Hamasaki
    Kida, Jun-ichiro
    Uemura, Makiko
    Fujita, Haruyuki
    Ohno, Hirofumi
    Ide, Makoto
    Ohnishi, Hiroaki
    Kadowaki, Norimitsu
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 949.e1 - 949.e8
  • [26] Prevalence, Risk Factors, and Outcomes of Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Bertelli, Luca
    Cazzato, Salvatore
    Belotti, Tamara
    Prete, Arcangelo
    Ricci, Giampaolo
    Pession, Andrea
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2017, 30 (02) : 113 - 115
  • [27] Renal complications after hematopoietic stem cell transplantation
    Abboud, Imad
    Pillebout, Evangeline
    Nochy, Dominique
    NEPHROLOGIE & THERAPEUTIQUE, 2014, 10 (03): : 187 - 199
  • [28] Late complications after hematopoietic stem cell transplantation
    Tichelli, Andre
    Rovo, Alicia
    Passweg, Jakob
    Schwarze, Carl Philipp
    Van Lint, Maria Teresa
    Arat, Mutlu
    Socie, Gerard
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (05) : 583 - 601
  • [29] Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation
    Cheng, Guang-Shing
    Edelman, Jeffrey D.
    Madtes, David K.
    Martin, Paul J.
    Flowers, Mary E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1169 - 1175